Show: October 18, 2009:
- PARP Inhibitors to Treat Breast Cancer
- Doc Chat: More Benefits to PARP Inhibitors
- Smoking Dulls Tastebuds
- Marijuana Linked to Testicular Cancer
- Living with HIV/AIDS
- Sperm Allergy
- Nobel Winner Elizabeth Blackburn on Telomeres
- How Money Affects the Brain
- View all topics for the week
PARP Inhibitors to Treat Breast Cancer
views 5695
Interview: James Ford, MD,
Associate professor of medicine, genetics and pediatrics
Stanford University School of Medicine
We pick up today where we left off last week, with more news about one of the most encouraging threads of research into the causes and treatments for breast cancer.
It’s an enzyme that’s in all of our cells, called PARP, which stands for: Poly-a-d-p-ribose polymerase. You can see why it’s called PARP.
One doctor who has been studying PARP is James Ford.
He’s on the faculty at Stanford University School of Medicine and is the co-author of a new study that has the breast cancer research community buzzing.
Additional Resources:
- Find out about cancer and genetic testing.
- Learn more about the PARP cancer drug study.







